Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1670 studies found for:    "Myelodysplastic syndromes"
Show Display Options
Rank Status Study
21 Completed
Has Results
An Extension to Study AZA PH GL 2003 CL 001 Allowing for Continuation of Azacitidine Treatment in Patients With Myelodysplastic Syndromes (MDS)
Condition: Myelodysplastic Syndromes
Intervention: Drug: Azacitidine
22 Active, not recruiting The Efficacy and Safety of Lenalidomide Monotherapy in Red Blood Cell Transfusion Dependent Subjects With Myelodysplastic Syndrome (MDS) Associated With Del (5q) Abnormality
Condition: Myelodysplastic Syndromes
Intervention: Drug: lenalidomide
23 Completed
Has Results
Study of CC-5013 to Evaluate Safety, Pharmacokinetics and Effectiveness for Japanese Patients With Symptomatic Anemia Associated With Myelodysplastic Syndrome With a Del(5)(q31-33) Abnormality.
Condition: Myelodysplastic Syndromes
Intervention: Drug: Lenalidomide
24 Completed Prognostic Molecular Markers in Patients With Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome
Intervention: Genetic: spliceosome
25 Terminated SIMIDIS: Azacitidine and Beta Erythropoietin Treatment in Patients With Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome
Interventions: Drug: Azacitidine;   Drug: Beta Erythropoietin
26 Active, not recruiting Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study
Condition: Myelodysplastic Syndromes
Interventions: Drug: Deferasirox;   Drug: Deferasirox placebo
27 Terminated Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Intervention: Drug: ATO + Ascorbic acid
28 Recruiting 5 Day Versus 7 Day Azacitidine in Lower Risk Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome
Intervention: Drug: Azacitidine
29 Completed Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome
Condition: Myelodysplastic Syndromes
Interventions: Drug: amifostine trihydrate;   Drug: azacitidine
30 Completed
Has Results
5-Azacytidine Prior to Allogeneic Stem Cell Transplant in High Risk Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome
Intervention: Drug: 5-azacytidine
31 Completed A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)
Condition: Myelodysplastic Syndromes
Intervention: Drug: Daclizumab
32 Completed Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome
Interventions: Drug: Antithymocyte globulin;   Drug: Cyclosporine
33 Completed
Has Results
A Study of JNJ-30979754 (Decitabine) in Patients With Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome
Interventions: Drug: JNJ-30979754 15 mg/m2;   Drug: JNJ-30979754 20 mg/m2
34 Terminated A Clinical Trial of Decitabine in Patients With Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome
Intervention: Drug: Subcutaneous Decitabine
35 Completed The Role of Erythropoietin in Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome
Intervention:
36 Recruiting PREDICTive FactOR of Overall Survival Among Geriatric Assessment Tools and Disease Related Factors in Elderly Patients With High Risk Myelodysplastic Syndromes.
Condition: Myelodysplastic Syndromes
Interventions: Other: research of disease-related factors;   Other: research of comorbidities;   Other: physical performance
37 Unknown  Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome
Condition: Myelodysplastic Syndromes
Intervention: Biological: anti-thymocyte globulin
38 Active, not recruiting Phase 2 Study of Pracinostat With Azacitidine in Patients With Previously Untreated Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome
Interventions: Drug: pracinostat;   Drug: Placebo;   Drug: Azacitidine
39 Completed
Has Results
A Study of Decitabine Given to Adults With Advanced-Stage Myelodysplastic Syndromes
Condition: Myelodysplastic Syndrome
Intervention: Drug: Decitabine
40 Completed APG101 in Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome
Interventions: Drug: Treatment with APG101;   Procedure: Bone marrow collection;   Procedure: Blood drawings

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.